Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Amgen Inc (AMGN): Today's Featured Health Care Winner
The Street
Saturday, June 22, 2013 - 10:22am
tags:
Amgen
CLOTS 3 Study Delivers Lifesaving Results Using Covidien’s Blood Clot Prevention Technology
Yahoo/BusinessWire
Saturday, June 22, 2013 - 10:21am
tags:
Covidien, blood clots, devices
Nanosphere Appoints Gene Cartwright, Ph.D. and Erik Holmlin, Ph.D. to its Board of Directors
Yahoo/AccessWire
Saturday, June 22, 2013 - 10:20am
tags:
Nanosphere, devices, Management
Cantel Medical Board Of Directors Announces 3-for-2 Stock Split And Authorizes Regular Semiannual Dividend
Yahoo/PRNewswire
Saturday, June 22, 2013 - 10:19am
tags:
Cantel Medical, Management, devices, stock
Anika Therapeutics: Profitable, Cheap And Overlooked
Seeking Alpha
Saturday, June 22, 2013 - 10:19am
tags:
Anika
Raptor Pharma's Procysbi Launched in the US
Yahoo/Zacks
Saturday, June 22, 2013 - 10:14am
tags:
Raptor Pharmaceuticals, procysbi, nephropathic cystinosis
John Garibotto Joins Cellnovo's Board of Directors
Yahoo/PRNewswire
Saturday, June 22, 2013 - 10:13am
tags:
Management, devices, Cellnovo
Positive Data for COV's Pipeline
Yahoo/Zacks
Saturday, June 22, 2013 - 10:13am
tags:
pipeline, devices, Covidien
Proxy war raises pressure on Vivus to fatten Qsymia sales
Yahoo/Reuters
Saturday, June 22, 2013 - 10:12am
tags:
Vivus, Qsymia
ViiV Healthcare Partnership Anticipates New HIV Treatment Approval
Seeking Alpha
Saturday, June 22, 2013 - 10:09am
tags:
ViiV Healthcare, GSK, Pfizer, Shionogi, Dolutegravir, HIV
J&J’s Pump Automatically Adjusts Insulin for Diabetics
Bloomberg
Saturday, June 22, 2013 - 10:05am
tags:
diabetes, insulin pump
Anthera Pharmaceuticals Announces Receipt of Nasdaq Notice
Yahoo/PR NewsWire
Saturday, June 22, 2013 - 10:03am
tags:
Anthera
Novartis Heart Drug Receives FDA Designation to Expedite Review
Motley Fool
Saturday, June 22, 2013 - 9:59am
tags:
Novartis
Why Idenix Pharmaceuticals Shares Were Put in Time-Out Again
Motley Fool
Saturday, June 22, 2013 - 9:46am
tags:
Idenix, IDX20963, hepatitis C
Pfizer Announces FDA Acceptance for Review of Application to Expand Labeling for XELJANZ® (tofacitinib citrate) for Adults with Moderately to Severely Active Rheumatoid Arthritis to Include Inhibition of Progression of Structural Damage
Yahoo/BusinessWire
Saturday, June 22, 2013 - 9:44am
tags:
rheumatoid arthritis, Xeljanz, Pfizer
FDA Accepts New Drug Application And Creates A Catalyst For Durect Corporation
Seeking Alpha
Saturday, June 22, 2013 - 9:39am
tags:
Durect Corporation, Posidur, post-operative pain, pain management
10 Top-selling Diabetes Drugs - 2012
Fierce Pharma
Friday, June 21, 2013 - 9:26am
tags:
diabetes, Merck, Januvia, Lantus, Sanofi, NovoRapid, Novo Nordisk, Eli Lilly, Humalog, Victoza, Levemir, Janumet, Novo Mix 30, Takeda, Actos
Ruconest Under FDA Review
Yahoo/Zacks
Friday, June 21, 2013 - 9:23am
tags:
Ruconest, FDA, Santarus, hereditary angiodema
Novartis Pregnancy Hormone Seen Lessening Heart Failures
Bloomberg
Friday, June 21, 2013 - 9:18am
tags:
Novartis, heart failure, RLX030
Idenix says FDA wants more safety data on experimental hepatitis C drug, delaying human trials
Yahoo/AP
Friday, June 21, 2013 - 9:16am
tags:
Idenix, FDA, hepatitis C, IDX20963

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.